Recruiting ENT and audiology patients into pharmaceutical trials: evaluating the multi-center experience in the UK and USA by Sanchez, Victoria A. et al.
For Peer Review Only
 
 
 
 
 
 
Recruiting ENT and Audiology patients into pharmaceutical 
trials: Evaluating the multi-center experience in the UK and 
USA 
 
 
Journal: International Journal of Audiology 
Manuscript ID TIJA-2017-06-0203.R2 
Manuscript Type: Original Paper 
Date Submitted by the Author: n/a 
Complete List of Authors: Sanchez, Victoria; University of South Florida, Department of 
Communication Sciences and Disorders 
Hall, Deborah; University of Nottingham, NIHR Nottingham Biomedical 
Research Centre’ ; University of Nottingham School of Medicine, Otology 
and Hearing group, Division of Clinical Neuroscience 
Millar, Bonnie; University of nottingham, NIHR Nottingham Biomedical 
Research Centre’ ; University of Nottingham School of Medicine, Otology 
and Hearing group, Division of Clinical Neuroscience 
Escabi, Celia; University of South Florida, Department of Communication 
Sciences and Disorders 
Sharman, Alice; Autifony Therapeutics Ltd, Autifony Therapeutics Ltd, 
Imperial Incubator, Level 1 Bessemer Building 
Watson, Jeannette; Autifony Therapeutics Ltd, Autifony Therapeutics Ltd, 
Imperial Incubator, Level 1 Bessemer Building 
Sornaraja, Thasma; Autifony Therapeutics Ltd, Autifony Therapeutics Ltd, 
Imperial Incubator, Level 1, Bessemer Building 
Harris, Peter ; Autifony Therapeutics Ltd, Autifony Therapeutics Ltd, 
Imperial Incubator, Level 1 Bessemer Building 
Keywords: Pharmacology, Aging, Speech Perception, Tinnitus 
  
 
 
E-mail: editor-ija@utdallas.edu  URL: http://mc.manuscriptcentral.com/tija
International Journal of Audiology
For Peer Review Only
Recruiting ENT and Audiology patients into pharmaceutical trials: Evaluating 
the multi-center experience in the UK and USA 
*†Victoria A Sanchez 1, *Deborah A Hall 2,3, Bonnie Millar 2,3, Celia D Escabi1, Alice 
Sharman 4, Jeannette Watson4, Sornaraja Thasma 4, Peter Harris 4 
 
*  Equal contribution as joint first authorship 
† Corresponding author 
 
 1 Department of Communication Sciences and Disorders, University of South 
Florida, 4202 E. Fowler Ave. PCD 1017, Tampa, FL  33620 
2 National Institute for Health Research (NIHR) Nottingham Hearing Biomedical 
Research Unit, 113 The Ropewalk Nottingham NG1 5DU  
3 Otology and Hearing group, Division of Clinical Neuroscience, School of Medicine, 
University of Nottingham, Nottingham, NG7 2UH  
4 Autifony Therapeutics Ltd, Imperial Incubator, Level 1 Bessemer Building, Imperial 
College London, SW7 2AZ 
 
Author emails: 
vasanchez@usf.edu 
deborah.hall@nottingham.ac.uk 
bonnie.millar@nottingham.ac.uk 
criffel@mail.usf.edu 
alice.grant@autifony.com  
jw@peptinnovate.com - co-author is now at: Peptinnovate, Stevenage Bioscience 
Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX.  
s.thasma@prorelixresearch.com – Note: This has changed since original submission 
peter.harris@autifony.com 
 
† Corresponding Author: Victoria A Sanchez, Department of Communication 
Sciences and Disorders, University of South Florida, 4202 E. Fowler Ave. PCD 1017, 
Tampa, FL  33620; vasanchez@usf.edu; 813.974.1262.  
 
Running header: Recruiting into ENT and Audiology Clinical Trials 
 
Page 1 of 46
E-mail: editor-ija@utdallas.edu  URL: http://mc.manuscriptcentral.com/tija
International Journal of Audiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Keywords:  
pharmacology, aging, speech perception, tinnitus 
 
 
Page 2 of 46
E-mail: editor-ija@utdallas.edu  URL: http://mc.manuscriptcentral.com/tija
International Journal of Audiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Recruiting into ENT and Audiology Clinical Trials 
1 
 
ABSTRACT  
 
Objective: Recruiting into clinical trials on time and on target is a major challenge, 
and yet often goes unreported. This study evaluated the adjustment to procedures, 
recruitment, and screening methods in two multi-center pharmaceutical randomized 
controlled trials (RCTs) for hearing-related problems in adults.  
Design: Recruitment monitoring and subsequent adjustment of various study 
procedures (e.g., eligibility criteria, increasing recruiting sites, recruitment methods) 
are reported. Participants were recruited through eight overarching methods: trial 
registration, posters/flyers, print publications, internet, social media, radio, 
databases, and referrals. The efficiency of the recruitment was measured by 
determining the number of people: (1) eligible for screening as a percentage of those 
who underwent telephone pre-screening; and, (2) randomized as a percentage of 
those screened.  
Study sample: A total of 584 participants completed the pre-screening steps, 491 
screened, and 169 participants were randomized. 
Results: Both RCTs completed adjustments to the participant eligibility, added new 
study sites, and additional recruitment methods. No single recruitment method was 
efficient enough to serve as the only route to enrollment.  
Conclusions: A diverse portfolio of methods, continuous monitoring, mitigation 
strategy, and adequate resourcing were essential for achieving our recruitment 
goals.  
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INTRODUCTION 
As new pharmaceutical treatments are being developed for hearing-related disorders 
in the adult population (e.g., age-related hearing loss [ARHL], tinnitus), hearing 
healthcare professionals may be asked to participate in the recruitment of 
participants into a clinical trial. Participant recruitment is an essential component of 
conducting a successful clinical trial, yet it is one of the most difficult and least 
predictable elements. Investigators often overestimate the number of available 
potential participants who meet the inclusion criteria (Thoma et al., 2010) and many 
of those whom meet eligibility fail to be recruited (Allen et al., 1998). No matter what 
the clinical specialty, many trials fall short of their recruitment targets (see McDonald 
et al., 2006; Strasser et al., 2013; Bower et al., 2014) and insufficient or untimely 
recruitment into Randomized Controlled Trials (RCTs) has serious consequences. 
When the planned sample size is not achieved, the risk of making the erroneous 
conclusion that a drug is not effective is increased and external validity is diminished. 
When initial recruitment strategies are not successful, the trial period may need to be 
extended or the number of recruiting sites increased, all of which increases 
resources and costs. Alternatively, the trial may be abandoned, results may not be 
publishable, or the findings may have little impact on patient health and wellbeing.  
While we are not aware of any specific publications related to factors 
influencing recruitment into hearing-related pharmaceutical trials, Hong et al. (2013) 
found that building relationships with key stakeholders was an important factor in 
recruiting firefighters into an RCT of a hearing protection program. This finding is 
perhaps not surprising as systematic reviews of strategies designed to improve 
recruitment into pharmaceutical trials also indicate that investigator and participant 
factors can influence recruitment rate (Fletcher et al., 2012; Treweek et al., 2013; 
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Huynh et al., 2014). In general, the results of these systematic reviews highlight the 
benefits of making the trial open rather than blinded so that participants know what 
treatment they will receive; providing financial incentives to participants; reducing 
clinician’s workload; frequent contact between the trial coordinator and clinicians/trial 
site; and continuous monitoring. The applicability of these approaches to increasing 
recruitment for hearing-related pharmaceutical intervention trials is unknown, 
particularly as none of the individual studies included in the systematic reviews 
related to hearing disorders.  
Although we are not aware of any published reports specific to recruitment 
into pharmaceutical trials for hearing-related disorders, recent trials within hearing 
healthcare show recruitment challenges. For example, Piccirillo and colleagues 
(2007) conducted an RCT of gabapentin for tinnitus funded by National Institute of 
Health and conducted in the United States (US). The recruitment goal was 160 
participants (80 gabapentin, 80 placebo), but closed with 135 enrolled (59 
gabapentin, 56 placebo). Considerable resources were likely expended on 
recruitment since 1028 participants were screened. The overall efficiency was low, 
with 669 (65%) of those screened not eligible and 224 (22%) of those eligible 
declining to participate. A majority of those excluded (n=514) had only mild self-
reported tinnitus severity. The high screen-failure rate is not isolated to this tinnitus 
RCT, as 48% of the 160 adults assessed for eligibility in a trial of an investigational 
medicinal product for the prevention of noise-induced hearing loss also failed to meet 
eligibility (Kil et al., 2017). In contrast, when normal hearing participants are being 
recruited a high efficiency can be achieved. For example Le Prell and colleagues 
(2016) had a relatively low screen failure rate (26%) in a study focused on a dietary 
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supplement to prevent music-induced hearing loss and recruited university students 
(aged 18-31 years) who had normal hearing. 
While challenges in participant recruitment are widely recognized in many 
areas of research, recruitment into pharmaceutical trials for hearing disorders may 
have some unique challenges. First is the relative complexity of current approaches 
to clinical management of hearing disorders, which can involve general practitioners 
(GPs), otologists (ENTs), and audiologists. Second is the relatively limited 
experience of the audiologists in participating in pharmaceutical RCTs. Increased 
understanding of the efficiency of methods which can be used to recruit into hearing-
related pharmaceutical trials may therefore be beneficial.  
The purpose of this report is to describe the recruitment monitoring and 
subsequent adjustment of various study procedures and describe the recruitment 
methods for two hearing-related phase IIa pharmaceutical RCTs: QUIET-1 (QUest In 
Eliminating Tinnitus) in England and CLARITY-1 in the US. Each RCT tested the 
same novel drug compound for associated hearing-related problems. The sponsor 
for both trials was the same, Autifony Therapeutics Ltd, despite the populations 
recruited being different across the two RCTs with different regulatory requirements 
based on country having an influence on methodologies. Clinical trial support was 
provided in both trials by the same ISO-certified international Contract Research 
Organization (CRO), CROMSOURCE. Hearing expertise support was provided to 
the sites by two academic partners: the University of Nottingham for QUIET-1 and 
the University South Florida (USF) for the CLARITY-1. Using data from the academic 
partners, our aim was to evaluate the recruitment monitoring and subsequent 
adjustment of various study procedures (e.g., eligibility criteria, increasing recruiting 
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sites, recruitment methods) and report the efficiency of recruitment and screening 
methods to achieve the planned sample size.  
Overview of the RCTs  
The QUIET-1 and CLARITY-1 trials had a number of common elements. Both 
compared the effect of repeat dosing of AUT00063 relative to a placebo control. 
AUT00063 is a synthetic molecule which modulates specific voltage-gated 
potassium ion channels present within the neurons of the central auditory system. 
Both QUIET-1 and CLARITY-1 were multi-center, randomized, double-blind, parallel 
group, placebo-controlled trials with the primary endpoint at 28 days after the first 
drug dosing day. Consented participants attended between five and six in-clinic visits 
spread across a maximum of 10 weeks, with up to two monitoring telephone calls. 
Financial compensation was offered to all participants. Once randomized, the drug 
was taken orally, once daily, for 28 days. Relevant ethical and regulatory agencies 
approved all procedures, compensation, and r cruitment methods.   
The two trials were open to recruitment in parallel. QUIET-1 targeted 
recruitment of up to 152 participants and enrollment was open from December 2014 
until October 2015. CLARITY-1 initially sought to recruit 100 participants and 
recruitment was active from March 2015 until April 2016. For both RCTs, the CRO 
assigned staff that served as personal contact points, resolved queries, conducted 
monitoring visits, and so on. Each site had a designated coordinator who weekly 
reported to the CRO the number of people pre-screened, the number of people 
attending a screening visit, the number of and reasons for screen failure, and 
randomization logs. Weekly recruitment reports for the trial as a whole were created 
by the CRO and monitored by the sponsor at a weekly teleconference.  
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Both RCTs utilized a structured telephone pre-screening interview asking 
questions about tinnitus/hearing loss, demographic factors, and general physical 
health status. There was a major primary difference between the two trials for pre-
screening. Specially, this related to use of a centralized versus decentralized pre-
screening approach. For QUIET-1, the Nottingham site was the central contact point 
and two trial administrators conducted telephone pre-screening interviews. Those 
who were potentially eligible were advised to contact their local site to book a 
screening visit, or ask their GP to write a letter. For CLARITY-1, pre-screening was 
decentralized, with each site independently responsible for telephone interviews.  
 Once the potential participants passed the telephone pre-screening they 
moved to on-site eligibility screening after completing the informed consent process. 
Measures to ensure general good health included physical examination, vital signs, 
urinalysis, hematology and biochemistry, medical history, electrocardiography, and 
medication review. A number of eligibility criteria were common to both RCTs and 
these are presented in Supplemental File A. The RCT designs had a number of 
additional differences relating to eligibility criteria, number and type of recruiting 
sites, and planned recruitment methods, as described below.  
Participant Eligibility 
For QUIET-1, the therapeutic target was subjective tinnitus associated with ARHL, 
and for CLARITY-1 it was difficulty understanding speech in noise associated with 
ARHL. For this reason, there were differences across the trials in terms of eligibility 
criteria. Table 1 provides details specific to the QUIET-1 trial, according to the final 
version of the Clinical Trial Protocol (version 1.5), while Table 2 provides details 
specific to CLARITY-1 according to the final protocol version (version 4.0). For 
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QUIET-1, audiometric testing ensured sensorineural hearing loss and the score on 
the Tinnitus Functional Index (TFI; Meikle et al., 2012) identified those with moderate 
to severe tinnitus symptoms (Table 1). For CLARITY-1 (Table 2), audiometric testing 
ensured a strict hearing loss configuration and a significant difficulty with 
understanding speech in noise measured by the Quick Speech-in-Noise Test 
(QuickSIN; Killion et al., 2004). Further screening tests excluded individuals with any 
other relevant impairments (e.g., cognitive impairment).  
** Insert Tables 1 and 2 about here ** 
Recruiting Sites  
It was anticipated that 10 National Health Service (NHS) hospital sites would be 
sufficient to recruit the 152 target for QUIET-1. Two ‘backup’ sites were identified as 
a mitigation for slow recruitment. Similarly, it was anticipated that 10 sites would be 
sufficient to reach the 100 target for CLARITY-1. All US sites were established ENT 
or Audiology practices or a research institute with a collaborating ENT/Audiology 
partner.  
 
Recruitment Methods  
Across both trials there were eight recruitment methods. The methods utilized were 
primarily the result of the academic partners’ experiences with recruitment into non-
pharmaceutical intervention studies for adults with ARHL and/or tinnitus in the two 
countries. Over the course of both trials, a small number of diverse methods to raise 
awareness of the study evolved. Both the initial planned methods and those that 
evolved over time are described below. 
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  (1) Trial Registration: In an effort to increase transparency to all individuals 
potentially interested in participation in clinical research, trial registration is required. 
QUIET-1 and CLARITY-1 were registered on ClinicalTrials.gov (NCT02315508 and 
NCT02345031, respectively). Information about CLARITY-1 was also registered on a 
second trial website (www.centerwatch.com). 
 (2) Posters/flyers: Both trials included the development and distribution of 
posters and flyers for display and dissemination. The four designs approved for 
QUIET-1 are shown in Supplemental File B, and the three designs for CLARITY-1 in 
Supplemental File C. For QUIET-1, 12,800 posters were printed using all four 
designs and 3,824 (31.6%) were distributed to GP centers, pharmacies, and local 
hospitals by all trial sites. One of the sites requested electronic pdfs for display 
screens in waiting rooms. Electronic versions of the CLARITY-1 materials were 
made available to all study sites for local customization. At USF, the posters were 
placed in multiple locations across the campus and electronic versions were posted 
on display screens in waiting rooms of the medical clinics.  
(3) Print Publications: QUIET-1 budgeted for one planned paid feature article 
in a regional community magazine which targeted the post-60 year-old age group. In 
addition, free-of-charge short editorials appeared in the health section of several 
tabloid newspapers reporting on Autifony Therapeutics Ltd or reporting on tinnitus 
and QUIET-1. Feature articles were also published in major hearing-related national 
magazines in the United Kingdom, targeting both members of the public and hearing 
healthcare professionals (i.e., British Tinnitus Association, ENT and Audiology News, 
Hearing Times, Hearing Link). The Nottingham QUIET-1 site placed paid short 
feature articles in six community magazines across the region, including one which 
targeted the post-60 year’s age group, numerous unpaid methods were also 
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introduced around Nottingham. These included: placing a short feature article in 
another community magazine distributing the four different poster to more diverse 
locations than initially planned (i.e., libraries, universities, GP centers, and 
pharmacies across the surrounding regions); and, electronic promotional activities by 
the lead academic site. While CLARITY-1 did not initially budget for any paid print 
recruitment methods, after nine months with less than expected participants enrolled 
in the study, Autifony Therapeutics Ltd placed a paid featured advertisement in 
‘Audiology Today’ (http://www.audiology.org/) with 12,000 professional members. In 
addition, two paid advertisements were placed in local newspapers (Tampa Bay 
Times and The Florida Healthcare News), with circulations of 35,000 and 20,000, 
respectively.  
 (4) Internet: Autifony Therapeutics Ltd created “clinical trial” webpages (no 
longer active) on their website which directed viewers to contacts for each trial. 
QUIET-1 feature articles and updates were published on the webpages of Action on 
Hearing Loss, British Tinnitus Association, and the lead academic site. CLARITY-1 
feature articles and updates were published on USF’s webpages and press releases 
were submitted to several online science and technology forums that provided 
readers with general information about the trial.  
(5) Social Media: QUIET-1 utilized social media platforms, but creating 
abbreviated recruitment announcements were posted into Facebook and Twitter by 
the local hospital (@nuhresearch ≈ 1,200 followers) and lead academic site 
(@hearingnihr ≈ 600 followers). These announcements were forwarded to additional 
pages. Although not a part of the original recruitment plan, the USF site engaged in a 
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social media campaign which focused on posting and sharing posts on various 
university-affiliated Facebook accounts. 
(6) Referral: Referrals from a hearing healthcare professional primarily came 
from each Principal Investigator or from other ENTs and audiologists. E-mail 
dissemination, presentations at clinician meetings, and word-of-mouth raised 
awareness and encouraged hearing health professionals to inform potential 
participants of the trial. Only done in CLARITY-1, other healthcare providers serving 
potential participants in the local area were sent a “Dear Doctor Letter” informing 
them about CLARITY-1. These routes were initially planned personal referrals in 
hopes of spreading the word about the study and encouraging individuals that knew 
about the study share with others as a form of personal referrals. Besides patient 
referrals from healthcare professionals, both sites utilized methods to increase 
personal referrals. In the Nottinghamshire area, updates appeared in the quarterly 
newsletter for the lead academic site which had a distribution of over 1,000 readers 
via post and email. For QUIET-1 ad hoc unplanned other personal referrals came 
from more informal channels, namely relevant charitable organizations with 
telephone helplines, Tinnitus Support Groups (including presentations to these 
groups), online discussion forums, and personal recommendation by word-of-mouth. 
Similarly for CLARITY-1, USF has an “opt-in” listserv for current and previous faculty, 
staff, and students who are willing to receive a variety of announcements including 
current study alerts. A study-alert message was sent to all employees on the USF 
listserv. In a similar fashion, USF also maintains alumni e-mail distribution lists and 
an announcement was sent to these lists informing subscribers about the CLARITY-
1 study.  
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(7) Radio: Numerous local BBC and commercial radio stations were used to 
broadcast short unpaid interviews with local trial site staff about tinnitus and the 
launch of QUIET-1. This method of recruitment was not utilized for CLARITY-1. 
(8) Database review: For CLARITY-1 the primary planned recruitment method 
was though database review, either an electronic medical record or other custom 
local database, for identification of potential participants. While the National Health 
Services in the United Kingdom does have electronic medical records, information 
about tinnitus is not systematically captured, so database review was not a viable 
method for the identification of potential participants for QUIET-1 trial.  
Recruitment Monitoring 
Recruitment tactics and other feedback to QUIET-1 sites occurred via email updates, 
six trial e-newsletters, an investigators’ kick-off meeting, and four teleconferences 
attended by site representatives, sponsor, and CRO. Feedback to CLARITY-1 sites 
with an initial Investigators’ kick-off meeting then summary updates occurred via 
email updates, eight e-newsletters, and two teleconferences.  
Analyses:  
The data obtained were first examined descriptively in terms of the ability to meet 
target goals as a function of protocol modifications (e.g., participant eligibility criteria, 
recruiting sites), and then the recruitment strategies utilized. The efficiency of 
recruitment method was calculated, as defined by Lloyd et al. (2010), as a function of 
the number of people that completed the telephone pre-screening and eligible for 
screening and also by determining the number of people randomized as a 
percentage of those screened. With respect to pre-screening efficiency calculation, 
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the Nottingham site conducted centralized pre-screening for QUIET-1 with those 
passing referred to the closest study site for onsite screening. For the CLARITY-1 
study, pre-screening data were only available for analysis from the primary academic 
partner site, USF. With respect to screening efficiency calculation, full records were 
kept at all sites on the number of people attending the screening visit and the 
number of screen failures; this allowed for the calculation of each site’s screening 
efficiency. The efficiency of the specific recruitment method leading to randomization 
was only available from Nottingham and USF. Finally, since efficiency needed to be 
balanced by a recruitment method’s cost-effectiveness, relevant data from the two 
primary academic partners, Nottingham for QUIET-1 and the USF for CLARITY-1, 
were examined. 
RESULTS 
Pre-specified target recruitment numbers were not met in either trial. For QUIET-1, 
91 of the 152 target were consented, screened, and randomized at which point a 
planned interim analysis was conducted. As is increasingly occurring in clinical trial 
practice, one purpose of the interim analysis was to determine whether or not the 
clinical trial, if continued, was likely to achieve its primary efficacy objective. For the 
QUIET-1 interim analysis, the futility criteria was met (p>0.39), leading to a 
recommendation that the study be discontinued and the sponsor accepted. 
Motivated by a slow recruitment rate into CLARITY-1, reconsideration of the 
statistical powering for the trial by the sponsor was conducted. Power was initially 
determined by a 3-dB improvement on the QuickSIN test, with an understanding that 
the initial target recruitment (n=100) was greater than indicated through power 
analyses (n=10), it was recommended that the recruitment goal decrease to 70 
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instead of 100, and the change was approved as part of Version 4.0 of the Clinical 
Trial Protocol on February 24, 2016. At the end of recruitment period (April 1, 2016) 
a total of 79 individuals were consented, screened, and randomized.  
Participant Eligibility Criteria Effect on Efficiency   
Active monitoring across sites occurred for both QUIET-1 and CLARITY-1. As a 
result of observing unexpectedly high screen fail rates, there were substantial 
amendments to both of the trials’ protocols.  
Participants in QUIET-1 could fail eligibility on multiple criteria but the most 
common reason being failure to meet audiometric criteria, which accounted for 44 of 
the 106 exclusions or 41.5% (Table 1). Although audiometric criterion became a 
concern early in the trial based on feedback from site audiologists, only one 
participant failed the eligibility screening prior to the first change to the criterion in 
protocol amendment in November 2014. Hence, there was insufficient ‘before’ data 
to explore the impact of this particular amendment. As shown in Table 1, a 
subsequent amendment in February 2015 relaxed the audiometric criterion again. 
Prior to this amendment, 5 of the 9 excluded participants (55.6%) had failed on 
hearing status. Following amendment, this proportion was reduced to 40.6% (39 out 
of 96).  
For CLARITY-1, the leading cause of the 277 screen failures, or 68% of total 
failures, was the absence of a significant speech-in-noise deficit as measured by the 
QuickSIN (see Table 2). The QuickSIN requirement could not be adjusted as the 
participants needed to demonstrate a deficit in speech-in-noise recognition and 
reducing the entry criteria would include clinically normal performance with no room 
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for improvement. However, relaxing the audiometric criteria defining ARHL did 
improve recruitment (Table 2).  
Recruiting Sites 
For both RCTs, more than the 10 planned sites were opened to support the slower 
than expected recruitment and mitigate for the delay in opening certain sites. Figure 
1 illustrates the location of all sites that screened participants.  
** Insert Figure 1 about here ** 
Tables 3 and 4 report the site timelines and the screening and randomization activity 
at each site. For QUIET-1, an additional eight sites including the two original 
backups were opened, while for CLARITY-1, three sites were added. Quick 
identification and qualification of new sites, as well as a focus on those familiar with 
delivering clinical trials were beneficial. 
** Insert Tables 3 and 4 about here ** 
Efficiency of Recruitment  
Table 5 displays the data from the sites of the academic partners for the different 
recruitment methods at the pre-screening and then screening stage for academic 
sites for the QUIET-1 and CLARITY-1 trials, respectively. In the table, the specific 
recruitment methods are listed under larger categories and these larger categories 
were essentially used in both RCTs with the exception of Radio being solely used in 
QUIET-1 and Database Review being a planned recruitment method for CLARITY-1. 
All recruitment methods are noted as either being Planned/Unplanned and 
Paid/Unpaid. Both RCTs added additional recruitment methods (unplanned) to 
increase recruitment along the course of the trials. While Posters/Flyers generated 
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the most pre-screens for QUIET-1 (n=102), this was a smaller recruitment mode for 
CLARITY-1 (n=14). Also interesting, the internet was a much more popular route for 
Nottingham (n=76) than at USF (n=2). These data were used to determine the 
efficiency of the recruitment methods in terms of (1) pre-screening and (2) screening 
as discussed below.  
** Insert Table 5 here ** 
 (1) Eligibility as a percentage of those who underwent telephone pre-
screening: Pre-screening efficiency  
The numbers of telephone pre-screening calls completed and the individuals who 
passed the pre-screening are reported in Table 5, and this information was also used 
to determine the pre-screening efficiency of the different recruitment methods (top 
panel, Figure 2).  A higher pre-screening efficiency indicates that people responding 
to a particular method were more likely to pass pre-screening and invited to attend 
an in-person screening visit.  
** Insert Figure 2 here** 
Nottingham was the pre-screening coordinating site for all QUIET-1 sites. The 
Nottingham staff conducted 425 structured pre-screening interviews between 
December 2, 2014 and October 8, 2015. Of these, 181 failed on a specific criterion 
for tinnitus (duration ≥6 months and ≤18 months at enrollment), with the majority 
(n=179) experiencing chronic tinnitus symptoms. A further 29 participants were 
excluded because they were taking concomitant medications that were not permitted 
in the clinical trial protocol. As can be seen in Figure 2, although the absolute 
number of planned referrals from a healthcare professional in QUIET-1 was small, 
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the efficiency of this route at pre-screening was the highest (58%), certainly relative 
to the more costly printed publication methods (40%), or poster campaigns (37%). 
Overall and across all recruitment methods, 235 recruits did not pass the pre-
screening were not eligible for an on-site screening visit, while 190 individuals were 
invited to attend a screening visit at the closest QUIET-1 site (45.7% efficiency). 
 Unlike QUIET-1 where Nottingham coordinated all pre-screening activity, 
each CLARITY-1 site conducted their own pre-screening. CLARITY-1 pre-screening 
data were completed at USF (Table 5, Figure 2). Between March 5, 2015 and April 
1, 2016 USF pre-screened 151 individuals, of whom 106 were excluded as not 
eligible, leading to an overall 29.8% pre-screening efficiency. Reasons for exclusion 
included: current or recent hearing aid use, demographics (age, English not the 
first/primary language, self-reported professional musicians), ineligible hearing loss 
(not age-related, caused by ototoxic medications, known asymmetry), use of 
prohibited medications, current enrollment in another study, and self-report of severe 
tinnitus. The CLARITY-1 team anticipated that the main source of recruitment would 
be from database review but while the absolute numbers were high (68 pre-screens), 
efficiency was low (16%). Beyond the database recruitment, the planned methods of 
trial registration (67%), posters/flyer distribution (36%), internet (50%), and referrals 
(37%) had a combined mean efficiency rate of 47.5%. The recruitment methods 
implemented later in the study (paid newspaper advertisements and social media) 
had a combined mean efficiency rate of 45.3%. 
 
 (2) Eligibility as a percentage of those who underwent screening: Screening 
efficiency  
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Data was recorded for all of the 214 screening visits conducted across the 15 
QUIET-1 sites (Table 3). Of these, 91 participants were randomized (42.5% 
efficiency), and the median efficiency across sites was 44% (Table 3). Efficiency may 
be underestimated since, within the remainder, six individuals had a decision 
pending further medical investigation, one person was eligible but declined to 
participate, and 10 individuals had been screened but were not taken further due to 
the study termination. In total, only six of the 123 participants (4.9%) identified as 
potential participants through telephone pre-screening strategy were excluded at the 
screening visit with the otologist consultant. Six were excluded for tinnitus duration, 
with the primary reason being duration. That is, the potential participants moved out 
of the eligible time window by the time of their screening appointment.  
Across all 13 CLARITY-1 sites, 277 participants were screened (Table 4). Of 
these, 79 participants were randomized (28.5% efficiency), and the median efficiency 
across sites was 24% (Table 4). At the USF site, 34 of the 45 participants (76%) 
were still excluded at the screening visit and so we conclude that the pre-screening 
strategy was only moderately effective. The moderate efficiency was caused by lack 
of ability to predict speech-in-noise performance; thus, results of QuickSIN were a 
major stumbling block. 
For both RCTs, Table 5 reports the total number of subjects screened on-site 
and randomized with respect to recruitment methods utilized at Nottingham and 
USF, and this information was also used to determine the screening efficiency of the 
different recruitment methods (bottom panel, Figure 2).  Because numbers are small, 
we do not interpret observed trends. However, worthy of note is that the internet 
channels were generally popular routes at the pre-screening stage, but did not yield 
any randomized participants at either site. In addition, both RCTs had acceptable 
Page 19 of 46
E-mail: editor-ija@utdallas.edu  URL: http://mc.manuscriptcentral.com/tija
International Journal of Audiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Recruiting into ENT and Audiology Clinical Trials 
18 
 
efficiency from the posters/flyers (43% for Nottingham, 60% for USF) although the 
pre-screening efficiency was lower for this method (37% for Nottingham, 36% for 
USF). Although the absolute number of healthcare professional was small, these 
routes were efficient for both RCTs, certainly relative to the more expensive printed 
publications methods. 
Resource implications 
For QUIET-1, printed media were the most costly method of recruitment. A 
recruitment plan was developed at the start of the trial by a graduate in journalism 
and marketing at a cost of £3,984. He prepared all of the features that fed into the 
newspaper, poster, and magazine advertisements. In addition to this, an estimate of 
the total cost for the poster campaigns was £3,150, including design, printing, 
stationery, and labor, and £1,050 for the magazine campaigns, including publication 
fees and labor. These figures are likely to be underestimated because labor costs for 
dealing with additional promotional opportuniti s were not recorded. Furthermore, 
labor costs for dealing with telephone and email queries, separate from the actual 
telephone pre-screening calls, is not accounted for. 
For CLARITY-1, printed advertisements in local newspapers were the only 
recruitment method with a direct site cost ($4,364). Again, this is an underestimate 
because labor costs of the study staff who designed the advertisements, obtained 
regulatory approval, and negotiated the placement in the newspaper were not 
available. Although the paid advertisements only yielded three pre-screening 
interviews, and none continued on to screening, the potential for good recruitment 
needs to be acknowledged. The two local advertisements were placed in March 
2016 with recruitment and enrollment closed on April 1, 2016. The number of calls 
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that could have potentially lead to successful recruitments were tallied to 34 
individuals from April to June. Thus, the paid advertisements may have been more 
cost-effective if initiated earlier in the recruitment phase. Experience suggests that 
the database review method was unlikely to be cost-effective. As an example of the 
effectiveness of database review, the USF database included 478 adults which was 
narrowed to 68 whom fit the age range, were known to have ARHL, and did not 
report using hearing aids at time of last contact. Despite the substantial labor 
demands needed to search all database records and complete the 68 identified 
contacts, only 11 individuals were eligible for screening and only two were 
randomized. 
The posters/flyers used to promote QUIET-1 turned out not to be so low-cost 
and low-resource, primarily because of the substantial labor required to manually 
enter the local contact details for each paper copy. The Nottingham site packaged 
and posted materials to other sites enabling us to at least track the demand across 
sites. For CLARITY-1, sites received electronic copies of posters/brochures and so 
greater responsibility for printing was locally delegated, with less opportunity for 
tracking poster-related promotional activities. 
Both the telephone pre-screening and screening visits demanded 
considerable labor to sustain. For the Nottingham QUIET-1 team, the resource 
demand was two-fold. First, the number and duration of calls was greater than 
planned. The protocol planned for a short (15 minute) call to assess duration of 
tinnitus, relevant medical history, and concomitant medications. However, calls 
occasionally lasted up to one hour and some conversations were challenging 
because the trial staff had to manage the person’s anticipation to find a cure and 
disappointment at being excluded. Second, organizing the screening visit was 
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logistically challenging since it required appointments with multiple professionals who 
were based across two hospital campuses. For CLARITY-1, the labor demand was 
principally attributable to the high number of screen fails due to the QuickSIN scores. 
To conserve resources, study staff were recommended to start the screening visit 
with the hearing assessment, thus reducing the likelihood of completing unnecessary 
invasive procedures such as specimen collection for hematology and biochemistry.  
DISCUSSION 
Multi-site randomized controlled clinical trials are relatively uncommon in 
ENT/Audiology clinics, but with high potential for novel interventions for ARHL and 
tinnitus there are likely to be more RCTs in the future. This is the first evaluation of 
recruitment methods in hearing-related, multi-site clinical trials in adults. The present 
work demonstrates the difficulties that may be encountered in ENT/Audiology 
recruitment. Based on our experiences, we have learned the importance of planning, 
budgeting, implementing, and monitoring a recruitment plan that is relevant for all 
sites includes paid advertisements and has adequate risk mitigation. In this 
Discussion, we reflect on the strengths and limitations of our different recruitment 
methods so that other study teams may take these into account when planning 
future multi-center pharmaceutical trials in ENT/Audiology. The primary caveat to our 
reflections is that the systematic collection of such data was not planned into the 
studies. As a consequence, such information is available in a reliable form only from 
the primary academic sites. 
Recruitment Methods: Strengths 
Although telephone pre-screening was labor intensive, in general it contributed 
positively to the efficiency of the screening visits because participants with 
Page 22 of 46
E-mail: editor-ija@utdallas.edu  URL: http://mc.manuscriptcentral.com/tija
International Journal of Audiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Recruiting into ENT and Audiology Clinical Trials 
21 
 
exclusions that were easily identifiable by verbal questioning could be ruled out. 
Nevertheless, in both RCTs a reasonably large proportion failed on audiological 
criteria that could only be assessed during an on-site visit. For QUIET-1, this was the 
audiometric threshold for identifying a sensorineural hearing loss, and for CLARITY-
1, it was performance threshold on the speech-in-noise recognition task. The 
sponsor’s and CRO’s experience in risk management promoted active monitoring. 
Regular communication with trial sites helped to identify the need for remedial action 
by substantive amendments to the eligibility criteria and by requesting each site to 
develop its own ad hoc recruitment plan. These steps contributed to the ultimate 
enrollment achievements.  
For both RCTs, the internet avenues achieved the greatest outreach for low 
cost and low resource, especially given that the majority were externally maintained. 
In most cases, trial-specific details could be found by active searching for hearing-
related research information. Evidence suggests that internet use by older adults 
makes this recruitment method worth considering. For example, about 59% of US 
adults aged >65 years use the internet, with 24% going online multiple times per day 
(Perrin, 2015; Anderson and Perrin, 2016). Based on our QUIET-1 experience, it 
appeared that people with chronic tinnitus were likely to use the internet to seek out 
information about clinical trials of tinnitus; in contrast, experience with CLARITY-1 
indicated that people with ARHL were less likely to do so. We note that another 
tinnitus-related clinical study successfully recruited at least 26% of its participants 
using internet recruitment methods (Handscomb et al., 2016) although data 
collection was internet based too which can enhance the success rate of this 
recruitment method (Rosa et al., 2015). Further research is warranted to determine 
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whether or not internet recruitments can be successful for studies aimed at people 
with ARHL.  
 Unpaid newspaper and radio feature sessions were most effective at specific 
points in the trial cycle. For the QUIET-1 trial, media channels published and 
broadcasted promotional stories 1) when the trial opened for recruitment nationally, 
2) when a new site opened for recruitment locally, and 3) if there was specific 
newsworthy link to the story. An example of the latter case was a large-scale 
campaign planned around the UK Tinnitus Awareness Week (February 2-8, 2015), 
with the resulting media coverage having a major (but transient) boost on telephone 
queries, such that Nottingham handled 90 telephone pre-screening interviews in 
February, compared to 14 in January and 57 in March. Although efficiency at pre-
screening was around 30%, the campaign did have some drawbacks. There was a 
strong likelihood of attrition because many callers lived more than 20-miles travelling 
distance from a recruiting site and a large number of calls came from London area, 
exceeding the capacity of the London site.  
Recruitment Methods: Limitations 
It has been commented that recruitment strategies which work for some studies 
often do not work well for others, and that it is important for sites to test out different 
recruitment methods to find out what works best (Kye et al., 2009). Nevertheless, our 
experiences can provide important lessons for ENT/Audiology. Across the two RCTs, 
recruitment proved to be more resource intensive and had a higher proportion of 
screen failures than initially anticipated during trial design and planning, requiring an 
extension to the recruitment period and the addition of sites. These recruitment 
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struggles are similar to those reported for other disciplines too (Lloyd et al. 2010; 
Usadi et al., 2015).  
Similarly reported by Usadi and collegues (2015), which discussed that 
collaborative communication was positive and beneficial in an evaluation of 
recruitment strategies for randomized controlled trials involving infertile couples, both 
QUIET-1 and CLARITY-1 held regular teleconferences between recruiting sites and 
the trial’s data coordinating center at which monthly enrollment data and effective 
recruitment strategies were shared, and good performing sites were acknowledged. 
Such techniques seek to achieve “buy-in” from collaborators by developing a sense 
of personal ownership and commitment, techniques perhaps more common to 
business marketing than to clinical research. While both of the present trials did 
maintain contact through newsletters and teleconferences, feedback from sites 
suggests that there was room for improvement. For both trials, sites certainly 
welcomed the opportunity to discuss recruitment rates, highlight difficulties they were 
facing, and successful recruitment outlets. However, each recruiting site could not 
always be represented at the teleconferences due to conflicting clinical priorities.  
While physician referral can be more effective than advertising strategies for 
some intervention trials (Lloyd et al., 2010; Usadi et al., 2015) professional clinical 
referral was not as successful as had been anticipated at either site. Major eligibility 
criteria were not routinely assessed in-clinic, so a reasonably large proportion failed 
on those criteria at the screening visit. For the same reason, in CLARITY-1, 
database review also proved to be a rather inefficient, and a large proportion of 
those contacted failed at pre-screening because they used hearing aids (see Table 
2). Like others (e.g., Usadi et al., 2015), professional referrals to CLARITY-1 were 
found to be most effective when there was an existing close relationship between 
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specialties and the trial team. Similarly, Lloyd et al. (2010) also commented that 
referral strategies are more successful and efficient than advertising strategies at 
recruiting community-dwelling stroke survivors. It is likely that referral was the most 
successful and efficient the referring physicians were able to determine if stroke 
survivors initially fulfilled the inclusion criteria prior to contacting the investigators, 
resulting in higher efficiency in terms of eligibility as a proportion of those screened. 
Of the eight participants coming from professional referral who were screened by 
USF, seven came from the wider USF health network (one ENT, six audiologists) 
and just one came from outside the USF practice. This could be because the within-
network referrals came from healthcare providers highly motivated to assist the 
primary coordinating site and so they actively looked out for potentially eligible 
participants. We also note that neither physician at the Nottingham or USF sites 
specialized in areas directly relevant to the target clinical population (i.e., pediatric 
and cochlear implant specialists); thus, the low referral from those physicians is 
perhaps not surprising.  
Concluding Remarks 
Taking a business approach to trials has been shown to be beneficial in several 
multi-center trials (McDonald et al., 2011). Adopting an explicit marketing plan, 
engaging charities or participants to act as champions, delivering effective messages 
to multiple audiences at multiple levels, and achieving clinician and public buy-in are 
all known business components (Francis et al., 2007). Additionally, researchers need 
to ensure that they have sufficient budget to not only support staff to recruit 
participants, but to fund the evaluation of recruitment strategies in clinical trials. Our 
management of QUIET-1 and CLARITY-1 touched upon these factors, but such 
business approaches were not consistently planned and resourced at the outset. 
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Further research is warranted to evaluate the effectiveness of recruitment strategies 
to ENT/Audiology clinical trials.  
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Figure legends 
Figure 1. Recruiting sites for QUIET-1 in England (left-hand panel) and for 
CLARITY-1 in the US (right-hand panel). 
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Figure 2. Efficiency of the different recruitment methods used in the QUIET-1 and 
CLARITY-1 RCTs. The top panel shows pre-screening efficiency measured by 
determining the number of people eligible for screening as a percentage of those 
who underwent telephone pre-screening. The bottom panel shows screening 
efficiency measured by the number of randomized participants as a percentage of 
those screened. 
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Tables (5 total) 
Table 1. Eligibility criteria that were specific to QUIET-1, including a history of 
approved substantial changes to the Clinical Trial Protocol.  
 
QUIET-1 specific inclusion criteria 
(version 1.5, July 9, 2015) 
History of substantial changes 
to the protocol 
Females of child-bearing potential must have 
a negative pregnancy test at screening and 
baseline visits, and practice two reliable 
methods of contraception throughout the 
study. 
V1.1 (Aug 14, 2014) amended to 
ensure that women use two 
methods of contraception 
Pure Tone Average (for frequencies at 0.5, 1, 
2, and 4 kHz) ≤60 dB hearing level (HL), 
across the two ears 
V1.3 (Nov 13, 2014) amended to 
include =20 and =60 dB HL in the 
Pure Tone Average calculation. 
 
V1.4 (Feb 9, 2015) requirement for 
Pure Tone Average ≥20 dB 
removed 
Sensorineural hearing loss defined by any 
single audiometric threshold estimate >20 dB 
for frequencies at 0.5, 1, 2, 4, 6 and 8 kHz  
V1.4 (Feb 9, 2015) individual 
frequency thresholds >20 dB 
instead of lower Pure Tone 
Average ≥20 dB 
Duration of tinnitus ≥6 months and ≤18 
months at enrollment 
 
English speaking male or female  
≥18 years of age  
UK residents, registered with a UK General 
Practitioner 
 
Stable tinnitus (consistent from day to day)  
Score ≥24 and ≤68 on the Tinnitus Functional 
Index (TFI; Meikle et al., 2012)  
 
If a hearing aid or sound generator user then 
confirmed consistent daily device usage over 
the past six months 
 
QUIET-1 specific exclusion criteria 
(version 1.5, July 2, 2015) 
History of substantial changes 
to the protocol 
Surgical or medical condition that would be 
expected to significantly affect absorption of 
medicines 
V1.3 (Nov 9, 2014) amended to 
include only those surgeries or 
medical conditions expected to 
affect absorption 
Any acute disabling tinnitus  
Central nervous system pathologies (such as 
Multiple Sclerosis, Parkinson’s disease etc). 
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Moderate or severe depression or 
generalized anxiety as indicated by a score of 
≥11 out of 21 on the Hospital Anxiety and 
Depression Scale (Zigmond & Snaith, 1983)  
 
Use of central nervous system active drugs 
except analgesics and those specified in the 
Clinical Trial Protocol 
 
Presence or history of relevant severe 
adverse reaction to any drug or a history of 
sensitivity to potassium channel modulators  
 
Tinnitus as a concomitant symptoms of a 
known ontological condition (including but not 
limited to otitis externa, otitis media, 
otosclerosis, cholesteatoma, Ménière’s 
disease, or other vestibular problems, 
acoustic neuroma, or temporo-mandibular 
joint disorder) 
 
Intermittent tinnitus (comes and goes from 
one day to the next) 
 
Pulsatile tinnitus (rhythmical sounds that 
often beat in time with the heartbeat) 
 
Severe hearing impairment such that verbal 
communication is unreliable 
 
Participation in a hearing study, involving an 
intervention, within three months from the last 
study visit 
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Table 2. Eligibility criteria that were specific to CLARITY-1, including a history of 
approved substantial changes to the Clinical Trial Protocol. 
 
CLARITY-1 specific inclusion 
criteria (version 4.3, February 24, 
2016) 
History of substantial changes to 
the protocol 
Males who are sexually active must 
use a barrier method, unless 
vasectomized. 
 
Females must be confirmed to be of 
non-childbearing potential.  
 
Speech-in-noise deficit as shown to 
be equal or greater than 5-dB signal-
to-noise ratio (SNR) on the QuickSIN 
test presented binaurally 
 
Audiology criteria: a) air conduction 
thresholds at 2 kHz ≤60 dB HL, b) 
pure tone audiometry at 0.5, 1 and 2 
kHz cannot exceed 45 dB HL, c) no 
air conduction threshold > 75 dB HL 
at 4 kHz in both ears, d) no greater 
than a 15 dB HL difference between 
ears, and e) no recent history of 
middle ear disease 
Version 3.0 (Oct 22, 2015) amended 
to relax configuration criteria removing 
restriction on air conduction at 250, 
500, and 1000 Hz ≤ 40 dB HL in both 
ears; and removed restriction of air 
conduction threshold being less than 
75 dB HL at 3000 and 6000 Hz  
Willing to refrain from significant non-
study medication following the 
baseline visit 
 
Mother-tongue American English, 
male or female 
 
50-89 years of age Version 3.0 (Oct 22, 2015) amended 
to relax age criteria from 60-89 years 
to 50-89 years of age 
Reporting difficulty in hearing speech 
in noisy environments 
 
CLARITY-1 specific exclusion 
criteria (version 4.3, February 24, 
2016) 
History of substantial changes to 
the protocol 
History of sudden onset hearing loss  
Present conductive hearing loss of 
greater than 15 dB difference 
between air- and bone-conduction 
audiometry at two or more 
consecutive frequencies 
 
Montreal Cognitive Assessment <22  
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Current hearing aid user or previous 
user of hearing aids ≤6 months ago 
(intermittent user) and ≤3 years 
(consistent user) 
 
Score >30 on the TFI (Meikle et al., 
2012) 
Version 3.0 (Oct 22, 2015) amended 
to relax tinnitus criteria from TFI 
greater than 24 to 30 
History of ototoxic medication such as 
cisplatin or history of dynamic 
cochlear pathology, or chronic middle 
ear disease 
 
Currently taking or planning to take 
medications that are prohibited by the 
Clinical Trial Protocol 
 
Professional musician with around 5 
years or more musical training and 
performance 
 
Any acute disabling illness  
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Table 3. Timeline for opening sites to QUIET-1 recruitment, with screening and randomization listings. Efficiency of recruitment at each site 
refers to the number of participants randomized as a percentage of those screened. It should be noted that a ‘per protocol’ population is not 
available and that a proportion of those randomized were not per protocol. Three sites were opened, but not listed because they did not screen 
any participants before the trial was terminated. *  = the Academic Partner was at site 01. 
 
Site 
number 
Date opened to 
recruiting 
Participants screened 
(n=214) 
Participants 
randomized to 
treatment (n=91) 
Efficiency 
(%) 
03 October 10, 2014 22 11 50 
09 October 10, 2014 12 6 50 
08 October 17, 2014 14 8 57 
02 October 23, 2014 32 14 44 
04 October 27, 2014 29 15 52 
10 November 3, 2014 13 6 46 
06 November 6, 2014 4 1 25 
13 January 21, 2015 9 4 44 
12 February 11, 2015 7 2 29 
01* February 17, 2015 28 7 25 
17 April 23, 2015 6 3 50 
18 May 14, 2015 14 6 43 
14 June 22, 2015 2 0 0 
15 June 22, 2015 10 4 40 
19 July 28, 2015 12 4 33 
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Table 4. Timeline for opening sites to CLARITY-1 recruitment, with screening and randomization listings. Efficiency of recruitment at each site 
refers to the number of participants randomized as a percentage of those screened. It should be noted that a ‘per protocol’ population is not 
available and that a proportion of those randomized were not per protocol. In particular, Ω denotes an inflated efficiency since the site randomized 
11 participants not according to protocol who may not have met the eligibility criteria. *  = the Academic Partner was at site 01. 
 
Site 
number 
Date opened to 
recruiting 
Participants 
screened (n=277) 
Participants 
randomized to 
treatment (n=78) 
Efficiency (%) 
01* March 5, 2015 45 11 24 
04 March 5, 2015 38 23 64Ω 
12 May 18, 2015 10 3 30 
13 May 26, 2015 19 7 37 
14 May 26, 2015 16 2 13 
15 June 9, 2015 22 2 9 
18 July 13, 2015 21 2 10 
05 August 15, 2015 8 4 50 
08 September 11, 2015 1 0 0 
11 September 9, 2015 32 4 13 
17 September 9, 2015 30 8 23 
02 October 2, 2015 6 1 0 
19 October 12, 2015 29 12 4 
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Table 5. Efficiency of the different recruitment methods used in the QUIET-1 and CLARITY-1 RCTs. QUIET-1 data was sourced 
from the Nottingham site. The number telephone pre-screened was 433, but eight of those were pending a decision at the point of 
study termination. Hence, number reported here n = 425. CLARITY-1 data was sourced from USF. At USF, 151 individuals were 
pre-screened up to the end of the study.  Each recruitment method is coded as either Unplanned (U) or Planned (P), Unpaid (U) or 
Paid (P).  
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Trial registration                                                    0 0 0 0  3 2 2 2  
clinicaltrials.gov, 
centrewatch 
     3 2 2 2 P,U 
Poster/Flyer                                                        102 38 7 3  14 5 5 3  
Supplemental file B 75 28 6 2 P,U      
Supplemental file C      14 5 5 3 P,U 
Community posts 27 10 1 1 U,U      
Print publication                                                     90 36 4 2  3 3 3 0  
Regional magazine 7 0 0 0 P,P      
Newspaper 60 25  0 0 P,U 3 3 3 0 U,P 
Tabloid magazines 10 4 2 1  P,U      
Community magazine 13 7  2 1  U,P      
National Autifony advert      0 0 0 0 U,P 
 Internet 80 46 5 0  2 1 1 0  
Websites, post forums 80 46 5 0 P,U      
Websites, press releases      2 1 1 0 P,U 
Social media 4 1 0 0  1 0 0 0  
Facebook, Twitter 4 1  0 0 P,U      
Facebook       1 0 0 0 U,U 
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Referral 57 33 5 1  60 23 23 4  
Professional  11 8  3 1 P,U 8 3 3 1 P,U 
Personal 46 25  2 0 U,U 52 20  20 3  P,U 
Radio 21 6 1 0       
Opening announcements  21 6  1 0 P,U      
Database review      68 11 11 2  
Clinic/Research database      68 11 11 2 P,U 
Unable to code 71 30 6 2       
TOTAL pre-screenings     425 190     151 45     
TOTAL screening 
visits    28 8 
   
45 11 
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List of supplemental online material 
 
Supplemental file A. Eligibility criteria common to QUIET-1 and CLARITY-1. 
*Denote QUIET-1 criteria that were captured in CLARITY-1 by the single criterion: 
“Screening laboratory safety test results all in normal limits or deemed non-clinically 
significant by the Investigator.” 
 
Supplemental file B. Four designs for recruitment posters and flyers for QUIET-1. 
 
Supplemental file C. Three recruitment poster designs for CLARITY-1.  
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Figure 1. Recruiting sites for QUIET-1 in England (left-hand panel) and for CLARITY-1 in the US (right-hand 
panel).  
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Figure 2. Efficiency of the different recruitment methods used in the QUIET-1 and CLARITY-1 RCTs. The top 
panel shows pre-screening efficiency measured by determining the number of people eligible for screening 
as a percentage of those who underwent telephone pre-screening. The bottom panel shows screening 
efficiency measured by the number of randomized participants as a percentage of those screened.  
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Supplemental file A.  Eligibility criteria common to QUIET-1 and CLARITY-1. *Denote QUIET-1 criteria 
that were captured in CLARITY-1 by the single criterion: “Screening laboratory safety test results all in 
normal limits or deemed non-clinically significant by the Investigator.” 
 
Common inclusion criteria 
Normal life expectancy for age 
Able to understand and comply with the requirements of the study and signed Informed Consent 
Form 
Common exclusion criteria  
Corrected QTc interval <330 ms in males or <340 ms in females or >450 ms for both males and 
females 
History of important cardiac, endocrine, pulmonary, neurologic, psychiatric, hepatic, renal, 
hematologic, immunologic, or other major diseases deemed clinically significant at the time of the 
study which might be jeopardized by entering the study 
Diabetes mellitus with an HbA1C>8% (64 mmol/mol) 
*Previous cardiac rhythm disorders or ECG rhythm abnormalities whether symptomatic or not, 
and considered to be clinically significant 
*Blood pressure and heart rate (in seated position) outside the ranges specified 
*Clinically relevant out-of-range values in any hematology, urinalysis or clinical chemistry tests 
Alcohol or drug abuse deemed clinically significant 
Non-study treatments for the management of tinnitus, severe insomnia, major depressive 
disorder, severe anxiety, or post-traumatic stress disorder.  
History of hypersensitivity or idiosyncratic reaction to any component of the test medication 
History of poor cooperation, non-compliance with medical treatment, or unreliability 
Participation in any clinical research study evaluating another investigational drug or therapy 
within 30 days or at least 5 half-lives (whichever is longer) 
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